SBL
PRVL

Sargent Bickham Lagudis’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Sargent Bickham Lagudis’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100
Closed -$2K – 1013
2020
Q4 		$2K Hold
100
– – ﹤0.01% 824
2020
Q3 		$1K Buy
+100
New +$1K ﹤0.01% 780